Rize Oncology Inc. (RZONF)

Rize Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0.07	0.35	1.16	1.36	1.8	0.18
Cash & Short-Term Investments	0.07	0.35	1.16	1.36	1.8	0.18
Cash Growth	-91.75%	-70.19%	-14.78%	-24.06%	898.49%	296.21%
Other Receivables	0.16	0.15	-	-	-	-
Receivables	0.16	0.15	-	-	-	-
Prepaid Expenses	0.18	0.07	0.03	0.05	0.15	-
Other Current Assets	-	-	-	-	-	0.19
Total Current Assets	0.41	0.57	1.19	1.41	1.94	0.37
Total Assets	0.41	0.57	1.19	1.41	1.94	0.37
Accounts Payable	0.18	0.12	0.08	0.03	0.06	0.21
Other Current Liabilities	-	0.01	0	0.01	0.02	-
Total Current Liabilities	0.18	0.13	0.08	0.04	0.09	0.21
Total Liabilities	0.18	0.13	0.08	0.04	0.09	0.21
Common Stock	4.89	4.89	4.2	4.2	4.18	1.25
Additional Paid-In Capital	1.87	1.86	1.66	1.63	1.48	0.79
Retained Earnings	-6.32	-6.09	-4.83	-4.28	-3.59	-1.88
Comprehensive Income & Other	-0.22	-0.22	0.09	-0.17	-0.2	-
Shareholders' Equity	0.22	0.45	1.11	1.37	1.86	0.16
Total Liabilities & Equity	0.41	0.57	1.19	1.41	1.94	0.37
Net Cash (Debt)	0.07	0.35	1.16	1.36	1.8	0.18
Net Cash Growth	-91.75%	-70.19%	-14.78%	-24.06%	898.49%	-
Net Cash Per Share	0.00	0.00	0.03	0.03	0.04	0.01
Filing Date Shares Outstanding	80.74	80.74	75.74	38.74	48.38	47.85
Total Common Shares Outstanding	80.74	80.74	38.74	38.74	48.38	38.51
Working Capital	0.22	0.45	1.11	1.37	1.86	0.16
Book Value Per Share	0.00	0.01	0.03	0.04	0.04	0.00
Tangible Book Value	0.22	0.45	1.11	1.37	1.86	0.16
Tangible Book Value Per Share	0.00	0.01	0.03	0.04	0.04	0.00

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 3, 2026

Data Sources Report a data error